| 111 |
DEFINE-DM Trial: Imaging- and Physiology-Guided State-of-the-Art PCI vs. CABG for DM and Multi-Vessel Disease |
Duk-Woo Park |
Apr. 17. 25 |
| 110 |
CABG Is Still Standard Choice for Left Main and Multi-Vessel Disease |
David Paul Taggart |
Apr. 17. 25 |
| 109 |
Left Main and Multi-Vessel Revascularization 2025: Updated Guidelines and Beyond |
Gregg W. Stone |
Apr. 17. 25 |
| 108 |
Left Main and Multi-Vessel Disease Revascularization: Updated Guideline and Beyond |
Seung-Jung Park |
Apr. 17. 25 |
| 107 |
Next RCT for DM and Three-Vessel Disease: DEFINE-DM Trial |
Duk-Woo Park |
Apr. 17. 25 |
| 106 |
Coronary Physiology for Left Main and Multivessel Disease |
William F. Fearon |
Apr. 17. 25 |
| 105 |
Complete Revascularization in ACS and Multivessel Disease |
Kevin Bainey |
Apr. 17. 25 |
| 104 |
Master's Key Case and Review: Multi-Vessel PCI in Acute Coronary Syndromes: Decision-Making With FFR or Intracoronary Imaging |
Shamir R. Mehta |
Apr. 16. 25 |
| 103 |
[Master's Opinion - Debate: OMT vs. Surgery for Multi-Vessel Disease in CCS] Surgery Is Still Standard |
David Paul Taggart |
Apr. 16. 25 |
| 102 |
[Master's Opinion - Debate: OMT vs. Surgery for Multi-Vessel Disease in CCS] OMT First |
Sripal Bangalore |
Apr. 16. 25 |
